Since its inception in 2011, Precipio’s (NASDAQ: PRPO) vision is to battle the problem of cancer misdiagnosis, by developing innovative technologies that improve diagnostic accuracy and laboratory workflow, delivering better results to patients and their physicians. In addition to robust R&D and commercial departments developing and bringing to market its proprietary products, Precipio also operates a clinical laboratory that serves as a testing ground for company products from its development phase to full utilization within the
clinical setting.
Precipio’s Products Division develops, produces, and sells proprietary diagnostic products to laboratories. Precipio also has a Clinical Diagnostics Division which operates the company’s CLIA/CAP laboratory, servicing oncologist practices and hospitals to provide comprehensive diagnostic services, while utilizing the same technologies developed by the Products Division.
Company Details
- Employees
- 82
- Founded
- -
- Address
- 4 Science Park,
- Phone
- (203)787-7888
- co****@****odx.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- precipiodx.com
- Keywords
- RxSense.
- HQ
- New Haven, CT
Precipio, Inc. Questions
Precipio, Inc.'s helpline number is (203)787-7888
Precipio, Inc.'s website is precipiodx.com
Precipio, Inc.'s LinkedIn profile is https://www.linkedin.com/company/precipio-diagnostics
Precipio, Inc. has
82 employees.
View email and phone details for 82
employees at Precipio, Inc..
Precipio, Inc.'s industry is
Hospitals and Health Care
Precipio, Inc.'s top competitors are
Precipio Health Strategies,
Neogenomics Laboratories,
Kiser Healthcare Solutions, Llc,
Featherstone Foods,
Clinmax Cro,
Percipio Health,
Sïparadigm Diagnostic Informatics,
Genomoncology,
Bkd Group,
Rxsense.
Precipio, Inc.'s support email address is contact@precipiodx.com
Precipio, Inc.'s categories are Hospitals and Health Care
Precipio, Inc.'s founding year is 2011
